A strategic collaboration agreement was signed in May between CRISPR Therapeutics and Sirius Therapeutics.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A strategic collaboration agreement was signed in May between CRISPR Therapeutics and Sirius Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CRISPR Therapeutics
company in Basel, Switzerland
Nothing else this week.
Related events
- CRISPR Therapeutics and Scribe Therapeutics presented at a Morgan Stanley conference, highlighting their competition in gene-editing therapeutics.
- CRISPR Therapeutics is discussing commercial priorities and expanding treatment access into new markets with an investment bank.
- CRISPR Therapeutics presented durability data on gene therapy at the European Society of Cardiology (ESC) Congress on August 28, 2026.
Coverage
Newest first; wire copies grouped- ZacksCRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound? It has been about a month since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have lost about 5.3